ADCT Trademark

Trademark Overview

On Monday, January 11, 2016, a trademark application was filed for ADCT with the United States Patent and Trademark Office. The USPTO has given the ADCT trademark a serial number of 86871990. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 26, 2020. This trademark is owned by ADC Therapeutics SA. The ADCT trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals for the treatment and prevention of cancer

Providing medical information; providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, health, and wellness

Pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals
adct

General Information

Serial Number86871990
Word MarkADCT
Filing DateMonday, January 11, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 26, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2017

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment and prevention of cancer
Goods and ServicesProviding medical information; providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, health, and wellness
Goods and ServicesPharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 19, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 19, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 19, 2016
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameADC Therapeutics SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressEpalinges 1066
CH
Party NameADC Therapeutics SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEpalinges 1066
CH

Trademark Events

Event DateEvent Description
Wednesday, October 26, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, October 26, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 26, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 18, 2020SOU EXTENSION 5 GRANTED
Friday, March 6, 2020SOU EXTENSION 5 FILED
Tuesday, March 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 6, 2020TEAS EXTENSION RECEIVED
Saturday, September 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 19, 2019SOU EXTENSION 4 GRANTED
Thursday, September 19, 2019SOU EXTENSION 4 FILED
Thursday, September 19, 2019TEAS EXTENSION RECEIVED
Monday, March 4, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2019SOU EXTENSION 3 GRANTED
Monday, March 4, 2019SOU EXTENSION 3 FILED
Monday, March 4, 2019TEAS EXTENSION RECEIVED
Thursday, September 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 4, 2018SOU EXTENSION 2 GRANTED
Tuesday, September 4, 2018SOU EXTENSION 2 FILED
Tuesday, September 4, 2018TEAS EXTENSION RECEIVED
Wednesday, March 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 19, 2018SOU EXTENSION 1 GRANTED
Monday, March 19, 2018SOU EXTENSION 1 FILED
Monday, March 19, 2018TEAS EXTENSION RECEIVED
Monday, March 19, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 19, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 25, 2017PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, June 7, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 7, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, June 7, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 13, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, December 13, 2016FINAL REFUSAL E-MAILED
Tuesday, December 13, 2016FINAL REFUSAL WRITTEN
Thursday, November 3, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 2, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 2, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 3, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 3, 2016NON-FINAL ACTION E-MAILED
Tuesday, May 3, 2016NON-FINAL ACTION WRITTEN
Tuesday, April 26, 2016ASSIGNED TO EXAMINER
Tuesday, January 19, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 14, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

adct information pharmaceuticals providing medical field drug pharmaceutical development services wellness